Organization
Università degli Studi di Milano
8 abstracts
2 posters
Abstract
Comparing 18F-FDG positron emission tomography (PET) and breast magnetic resonance imaging (MRI) to predict pathological complete response (pCR) and 3-year invasive disease-free survival (3-y iDFS) in patients (pts) with HER2+ early breast cancer (EBC): An unplanned exploratory analysis of PHERGain trial.Org: International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA),
Abstract
Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies.Org: Samsung Medical Centre, International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Memorial Sloan Kettering Cancer Center,
Abstract
MOUNTAINEER-03: Phase 3 study of tucatinib, trastuzumab, and modified FOLFOX6 as first line treatment in HER2+ metastatic colorectal cancer.Org: Mayo Clinic, University Hospitals Gasthuisberg Leuven, KU Leuven, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Institute of Oncology (VHIO), Barcelona,
Abstract
Sotorasib (Soto) plus panitumumab (Pmab) and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer (mCRC): CodeBreaK 101 phase 1b safety and efficacy.Org: University of Texas MD Anderson Cancer Center, National Cancer Center Hospital East, Kashiwa, Japan, Duke University Medical Center, City of Hope National Medical Center, Cliniques Universitaires Saint-Luc,
Abstract
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety.Org: University of Brescia, ASST Spedali Civili - Brescia, Angelo Nocivelli Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili, ASST-Spedali Civili of Brescia,
Abstract
High-dose vitamin C to enhance neoadjuvant immune checkpoint therapy in mismatch repair proficient colon cancer: The ALFEO pilot study.Org: Università degli Studi di Milano, Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, University of Turin, Candiolo Cancer Institute-FPO, IRCCS,
Abstract
Effect of SNPs in TMPRSS2 to severe COVID-19 in patients with prostate cancer.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Molecular Immunology Unit, Department of Experimental Oncology, Programma Prostata,
Abstract
ACUTE EFFECT OF ILOPROST ON PERIPHERAL CIRCULATION AS ASSESSED BY VIDEOCAPILLAROSCOPY AND 22-MHZ POWER DOPPLER ULTRASONOGRAPHY Org: Università degli Studi di Milano, ASST Pini-CTO, Division of Clinical Rheumatology, Milano, Italy, Lab of Medical Statistics, Epidemiology and Biometry GA Maccacaro, Milan, Italy,